Parkside Financial Bank & Trust’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3K | Buy |
646
+12
| +2% | +$432 | ﹤0.01% | 1177 |
|
|
2025
Q1 | $19.7K | Buy |
634
+221
| +54% | +$6.88K | ﹤0.01% | 1150 |
|
|
2024
Q4 | $10.5K | Buy |
413
+82
| +25% | +$2.09K | ﹤0.01% | 1254 |
|
|
2024
Q3 | $9.36K | Buy |
331
+12
| +4% | +$339 | ﹤0.01% | 1264 |
|
|
2024
Q2 | $8.43K | Buy |
319
+29
| +10% | +$766 | ﹤0.01% | 1232 |
|
|
2024
Q1 | $8.81K | Sell |
290
-3
| -1% | -$91 | ﹤0.01% | 1209 |
|
|
2023
Q4 | $8.22K | Buy |
293
+158
| +117% | +$4.44K | ﹤0.01% | 1186 |
|
|
2023
Q3 | $3.66K | Buy |
135
+59
| +78% | +$1.6K | ﹤0.01% | 1477 |
|
|
2023
Q2 | $2.34K | Buy |
76
+48
| +171% | +$1.48K | ﹤0.01% | 1642 |
|
|
2023
Q1 | $1.01K | Sell |
28
-58
| -67% | -$2.09K | ﹤0.01% | 1846 |
|
|
2022
Q4 | $3.4K | Hold |
86
| – | – | ﹤0.01% | 1485 |
|
|
2022
Q3 | $3K | Hold |
86
| – | – | ﹤0.01% | 1446 |
|
|
2022
Q2 | $4K | Hold |
86
| – | – | ﹤0.01% | 1365 |
|
|
2022
Q1 | $3K | Buy |
86
+11
| +15% | +$384 | ﹤0.01% | 1523 |
|
|
2021
Q4 | $3K | Buy |
75
+70
| +1,400% | +$2.8K | ﹤0.01% | 1528 |
|
|
2021
Q3 | $0 | Sell |
5
-24
| -83% | – | ﹤0.01% | 1835 |
|
|
2021
Q2 | $1K | Buy |
+29
| New | +$1K | ﹤0.01% | 1658 |
|